IOVANCE BIOTHERAPEUTICS, INC. Increase (Decrease) in Other Current Assets
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) reported Increase (Decrease) in Other Current Assets of $19.95 million for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2016-03-11
- IOVANCE BIOTHERAPEUTICS, INC. increase (decrease) in other current assets for the quarter ending 2015-12-31 was -$617.00K.
- IOVANCE BIOTHERAPEUTICS, INC. increase (decrease) in other current assets for the quarter ending 2015-09-30 was $13.09M.
- IOVANCE BIOTHERAPEUTICS, INC. increase (decrease) in other current assets for fiscal 2015 was $19.95M.
- IOVANCE BIOTHERAPEUTICS, INC. increase (decrease) in other current assets for fiscal 2014 was $0.00.
- IOVANCE BIOTHERAPEUTICS, INC. increase (decrease) in other current assets for fiscal 2013 was $0.00.
| Period end | Increase (Decrease) in Other Current Assets 3 month | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 9 month | Increase (Decrease) in Other Current Assets 12 month |
|---|---|---|---|---|
| 2015-12-31 | -$617.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $12.47M derived: sum of 2 quarters · filed 2016-03-11 | $19.95M 10-K · filed 2016-03-11 | |
| 2015-09-30 | $13.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $20.56M 10-Q · filed 2015-11-06 | ||
| 2015-06-30 | $7.48M 10-Q · filed 2015-08-10 | |||
| 2014-12-31 | $0.00 10-K · filed 2016-03-11 | |||
| 2013-12-31 | $0.00 10-K · filed 2016-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |